# Carmenta Bioscience, Inc. — Form D

Carmenta Bioscience, Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-07-30. The offering totals $1.9M, of which $586K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2013-07-30
- Form: D
- Accession: 0001582250-13-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $1.9M
- Amount sold: $586K
- Remaining: $1.3M
- Investors: 25
- Date of first sale: 2013-07-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-200422

## Issuer

- Name: Carmenta Bioscience, Inc.
- CIK: 0001582250
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 4240 WILKIE WAY, PALO ALTO, CA, 94306
- Phone: 650-815-1320

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Atul Butte | Director | Palo Alto, CA |
| Matthew Cooper | Director | Ann Arbor, MI |
| Bruce Ling | Director | Palo Alto, CA |
| Matthew Cooper | Executive Officer | Ann Arbor, MI |

## More

- [CIK 1582250 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1582250&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001582250-13-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.